https://orcid.org/0000-0001-5673-9945
References
- James N. G, Nester CM. Syndromes of thrombotic microangiopathy. N Engl J Med. 2014;371(7):654–666.
- Chiasakul T, Cuker A. Clinical and laboratory diagnosis of TTP: an integrated approach. Hematol Am Soc Hematol Educ Progr. 2018;2018(1):530–538.
- Coppo P, Busson M, Veyradier A, et al. HLA-DRB1*11: a strong risk factor for acquired severe ADAMTS13 deficiency-related idiopathic thrombotic thrombocytopenic purpura in Caucasians. J Thromb Haemost. 2010;8(4):856–859.
- Gibson JS, Rees DC. How benign is sickle cell trait? EBioMedicine. 2016;11(C):21–22.
- Naik RP, Smith-Whitley K, Hassell KL, et al. Clinical outcomes associated with sickle cell trait: a systematic review. Ann Intern Med. 2018;169(9):619.
- Alvarez O, Rodriguez MM, Jordan L, et al. Renal medullary carcinoma and sickle cell trait: A systematic review. Pediatr Blood Cancer. 2015;62(10):1694–1699.
- Padmanabhan A, Connelly-Smith L, Aqui N, et al. Guidelines on the use of therapeutic apheresis in clinical practice – evidence-based approach from the writing committee of the American society for apheresis: the eighth special issue. J Clin Apher. 2019;34(3):171–354.
- Scully M, Cataland SR, Peyvandi F, et al. Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura. N Engl J Med. 2019;380(4):335–346.
- Bolaños-Meade J, Keung Y-K, López-Arvizu C, et al. Thrombotic thrombocytopenic purpura in a patient with sickle cell crisis. Ann Hematol. 1999;78(12):558–559.
- Chinowsky MS. Thrombotic thrombocytopenic purpura associated with sickle cell-hemoglobin C disease. South Med J. 1994;87(11):1168–1171.
- Majjiga VS, Tripathy AK, Viswanathan K, et al. Thrombotic thrombocytopenic purpura and multiorgan system failure in a child with sickle cell-hemoglobin C disease. Clin Pediatr. 2010;49(10):992–996.
- Geigel EJ, Francis CW. Reversal of multiorgan system dysfunction in sickle cell disease with plasma exchange. Acta Anaesthesiol Scand. 1997;41(5):647–650.
- Lee H, Marder V, Logan L, et al. Life-threatening thrombotic thrombocytopenic purpura (TTP) in a patient with sickle cell-hemoglobin C disease. Ann Hematol. 2003;82(11):702–704.
- Chatiwala JS, Guron G, Sidhom I. Thrombotic thrombocytopenic purpura in a patient with sickle cell crisis. Blood. 2006;108(11):3963–3963.
- Vlachaki E, Agapidou A, Neokleous N, et al. Thrombotic thrombocytopenic purpura or immune thrombocytopenia in a sickle cell/β+-thalassemia patient: a rare and challenging condition. Transfus Apher Sci. 2014;51(2):175–177.
- Chehal A, Taher A, Shamseddine A. Sicklemia with multi-organ failure syndrome and thrombotic thrombocytopenic purpura. Hemoglobin. 2002;26(4):345–351.
- Gangemi AJ, Pickens PV. Coagulopathy and functional hyposplenism during an episode of thrombotic thrombocytopenic purpura in a HgbS/β+-thalassemia patient. Clin Case Reports. 2015;3(7):521–526.
- Prichard JG, Clark HG, James RE. Abdominal pain and sicklemia in a patient with sickle cell trait. South Med J. 1988;81(10):1312–1314.
- Yale SH, Nagib N, Guthrie T. Approach to the vaso-occlusive crisis in adults with sickle cell disease. Am Fam Physician. 2000;61(5):1349–1356.
- Griffin D, Al Nouri Z, Muthurajah D, et al. First symptoms in idiopathic thrombotic thrombocytopenic purpura (TTP) what are they and when do they occur? Blood. 2010;116(21):1427–1427.
- Josephson CD, Su LL, Hillyer KL, et al. Transfusion in the patient with sickle cell disease: a critical review of the literature and transfusion guidelines. Transfus Med Rev. 2007;21(2):118–133.
- Meyer SC, Sulzer I, Lämmle B, et al. Hyperbilirubinemia interferes with ADAMTS-13 activity measurement by FRETS-VWF73 assay: diagnostic relevance in patients suffering from acute thrombotic microangiopathies. J Thromb Haemost. 2007;5(4):866–867.
- Test Definition: ADM13 Test Definition: ADM13. Mayo Clinic Laboratories. 2021: 1–5. [cited 18 Jan 2021]. https://www.mayocliniclabs.com/test-catalog/Overview/61212.